Skip to main content

and
  1. Article

    Open Access

    Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021

    Direct-acting antivirals (DAAs) for hepatitis C treatment in China became available since 2017. This study expects to generate evidence to inform decision-making in a nationwide scale-up of DAA treatment in Ch...

    **nyu Du, Jiarun Mi, Hanchao Cheng, Yuanyuan Song in Infectious Diseases of Poverty (2023)